Night Contact Lenses Market to Reach a Revenue of Around US$ 1.8 Billion by the End of 2032 at a CAGR of 7.5%: Study by Persistence Market Research
February 23, 2023 08:00 ET
|
Persistence Market Research
New York, Feb. 23, 2023 (GLOBE NEWSWIRE) -- The Night Contact Lenses Market is at US$ 880.3 Million in 2022 and is expected to increase at a CAGR of 7.5% over the forecast period (2023-2032). Key...
Clinical trials results demonstrate value of home OCT at international meetings
February 22, 2023 08:00 ET
|
Notal Vision
Manassas, VA, Feb. 22, 2023 (GLOBE NEWSWIRE) -- Notal Vision, Inc. reported today that the latest data on its investigational home-based optical coherence tomography (OCT) and how the service can be...
Genome Editing Market size to Cross US$ 108.4 Billion and grow at a CAGR of 34% By 2033-end, States Persistence Market Research
February 21, 2023 09:00 ET
|
Persistence Market Research
New York, Feb. 21, 2023 (GLOBE NEWSWIRE) -- The Genome Editing Market revenues were estimated at US$ 4.5 Billion in 2022 and are anticipated to grow at a CAGR of 34% from 2023 to 2033, according to...
Frontera Therapeutics Doses First Patient in a Trial of FT-002 Gene Therapy for the Treatment of X-Linked Retinitis Pigmentosa
February 16, 2023 08:00 ET
|
Frontera Therapeutics
BEDFORD, Mass. and SHANGHAI, China, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Frontera Therapeutics, a global clinical-stage biotechnology company that seeks to develop novel and best-in-class gene therapy...
ONL Therapeutics to Present at the XXVth Biennial Meeting of the International Society for Eye Research
February 13, 2023 07:00 ET
|
ONL Therapeutics
ANN ARBOR, Mich., Feb. 13, 2023 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal...
Opthea Phase 2b Trial Results of OPT-302 in Combination with Lucentis® for wet AMD Published in the Journal Ophthalmology
February 13, 2023 06:00 ET
|
Opthea Limited
MELBOURNE, Australia, Feb. 13, 2023 (GLOBE NEWSWIRE) -- Opthea Limited (NASDAQ:OPT; ASX:OPT), a clinical stage biopharmaceutical company developing novel therapies to treat highly prevalent and...
Blood Banking Equipment Market Worth $24.26 Billion by 2030 - Exclusive Report by Meticulous Research®
February 09, 2023 10:00 ET
|
Meticulous Market Research Pvt. Ltd.
Redding, California, Feb. 09, 2023 (GLOBE NEWSWIRE) -- According to a new market research report titled, ‘Blood Banking Equipment Market by Product (Collection [Tubes, Bags, Syringes], Processing...
Atsena Therapeutics to Present Positive Interim Encore Data from the Phase I/II Clinical Trial of ATSN-101 for the Treatment of GUCY2D-associated Leber Congenital Amaurosis (LCA1) at the 46th Annual Macula Society Meeting
February 08, 2023 07:30 ET
|
Atsena Therapeutics
DURHAM, N.C., Feb. 08, 2023 (GLOBE NEWSWIRE) -- Atsena Therapeutics, a clinical-stage gene therapy company focused on bringing the life-changing power of genetic medicine to reverse or prevent...
Global Surgical Microscope Market – Global Industry Size, Share, Trends, Opportunity, & Forecast, 2027F
February 08, 2023 07:03 ET
|
ReportLinker
New York, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Surgical Microscope Market – Global Industry Size, Share, Trends, Opportunity, &...
Harvard Eye Associates is the First to Implant the New IC-8® Apthera™ Intraocular Lens in Orange County, CA
February 06, 2023 14:00 ET
|
Harvard Eye Associates
LAGUNA HILLS, Calif., Feb. 06, 2023 (GLOBE NEWSWIRE) -- Harvard Eye Associates, a multi-specialty ophthalmology practice, implanted the first IC-8® Apthera™ intraocular lens (IOL) in Orange County,...